Raymond James Financial Services Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$1.45M Sell
56,471
-6,103
-10% -$156K ﹤0.01% 1918
2024
Q2
$1.47M Sell
62,574
-20,586
-25% -$483K ﹤0.01% 1847
2024
Q1
$2.39M Sell
83,160
-12,789
-13% -$368K ﹤0.01% 1551
2023
Q4
$3.15M Sell
95,949
-10,776
-10% -$354K 0.01% 1324
2023
Q3
$2.97M Sell
106,725
-5,853
-5% -$163K 0.01% 1284
2023
Q2
$3.84M Sell
112,578
-190,039
-63% -$6.48M 0.01% 1164
2023
Q1
$9.1M Buy
302,617
+14,521
+5% +$437K 0.02% 736
2022
Q4
$8.13M Sell
288,096
-16,749
-5% -$473K 0.02% 739
2022
Q3
$10M Sell
304,845
-152,628
-33% -$5.02M 0.02% 613
2022
Q2
$14.4M Buy
457,473
+215,575
+89% +$6.79M 0.03% 508
2022
Q1
$11.1M Sell
241,898
-9,505
-4% -$437K 0.02% 647
2021
Q4
$15.4M Sell
251,403
-93,924
-27% -$5.75M 0.03% 525
2021
Q3
$25.8M Buy
345,327
+31,230
+10% +$2.33M 0.05% 351
2021
Q2
$29.1M Sell
314,097
-61,000
-16% -$5.64M 0.06% 321
2021
Q1
$33.3M Buy
375,097
+83,159
+28% +$7.38M 0.08% 267
2020
Q4
$27.2M Buy
291,938
+104,887
+56% +$9.78M 0.07% 280
2020
Q3
$11.9M Sell
187,051
-16,646
-8% -$1.06M 0.03% 447
2020
Q2
$10.6M Buy
203,697
+39,440
+24% +$2.06M 0.03% 446
2020
Q1
$5.14M Buy
164,257
+64,541
+65% +$2.02M 0.02% 538
2019
Q4
$3.34M Buy
99,716
+36,628
+58% +$1.23M 0.01% 900
2019
Q3
$1.86M Buy
63,088
+19,711
+45% +$582K 0.01% 1141
2019
Q2
$1.5M Sell
43,377
-61,773
-59% -$2.13M 0.01% 1262
2019
Q1
$3.46M Buy
105,150
+81,244
+340% +$2.67M 0.01% 798
2018
Q4
$573K Buy
23,906
+14,495
+154% +$347K ﹤0.01% 1581
2018
Q3
$315K Buy
+9,411
New +$315K ﹤0.01% 2244